Fannie Mae Issues Governance Framework on Use of Artificial Intelligence and Machine Learning

The U.S. Patent and Trademark Office (USPTO) has updated its patent subject-matter eligibility guidance to address inventions involving artificial intelligence (AI). Our Intellectual Property Team examines how the revised guidance will impact AI patent strategies.

Our FDA/Food, Drug & Device Team examines how the Food and Drug Administration is approaching the preclearance and approval process for artificial intelligence (AI) and machine learning (ML) components in products under its purview.

The Securities and Exchange Commission (SEC) has retracted 14 rule proposals issued in 2022 and 2023. Our Investment Funds Team examines what the SEC’s withdrawal means for investment advisers going forward.

The ubiquity of artificial intelligence (AI) has heightened companies’ exposure to cyberattacks of increasingly greater sophistication. Our Privacy, Cyber & Data Strategy Team explores how businesses can enhance their security measures to mitigate the threat.

Our Privacy, Cyber & Data Strategy Group analyzes important guidance from the NYDFS on how insurers use external consumer data and information sources and artificial intelligence systems.